Firstbone FBB
This product represents one of the most advanced solutions in synthetic bone grafting, offering a fully sterile, high-purity biomaterial engineered to meet the rigorous demands of modern regenerative medicine. It is composed of a scientifically balanced combination of 75% Hydroxyapatite (HAp)—a highly stable, osteoconductive mineral that closely mimics the natural structure of human bone—and 25% Beta-Tricalcium Phosphate (β‑TCP), a resorbable calcium phosphate known for its controlled degradation rate. Together, this biphasic formulation provides the ideal synergy between structural stability and predictable resorption, ensuring optimal conditions for long-term bone regeneration.
The material features a multidirectional, interconnected porous architecture, carefully designed to support and guide the natural three-dimensional growth of new bone tissue. This porous network allows for effective cell migration, vascular ingrowth, nutrient exchange, and the gradual deposition of new bone matrix, ultimately promoting efficient and harmonious bone remodeling.
Thanks to its biphasic resorption profile, the graft maintains mechanical integrity during the early healing stages while gradually resorbing in parallel with the formation of new bone. This balanced behavior makes it particularly suitable for surgeons and clinicians who prefer grafts that behave similarly to natural bone sources, offering both reliable support and seamless biological integration.
Firstbone FBT
This product is a fully sterile, synthetic bone graft material composed entirely of pure beta‑tricalcium phosphate (β‑TCP), a highly biocompatible compound widely recognized for its predictable resorption and excellent osteoconductive properties.
During the natural bone‑healing process, the material gradually resorbs and is fully replaced by newly formed bone tissue, ensuring a harmonious and biologically integrated regeneration cycle. Its engineered structure features a multidirectional, interconnected porous network that facilitates rapid osteoblast migration, enabling efficient three‑dimensional bone regeneration and optimal vascular ingrowth.
The graft was specifically developed to provide an exceptionally high level of porosity—essential for cellular infiltration and bone formation—while maintaining sufficient mechanical strength to support the defect site during the early stages of healing. This balance between porosity and structural integrity makes it a reliable solution for clinicians seeking predictable and effective regenerative outcomes.